Evidence map›Paper›PMID 40928529›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study.

Thomas Lawler, Kristine Kwekkeboom, Shaneda Warren Andersen, Ajay K Sethi, Amye J Tevaarwerk, Kristin Litzelman, Priyanka A Pophali, Ronald E Gangnon, John M Hampton, Noelle K LoConte and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thomas LawlerCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA. tlawler2@wisc.edu.ORCID http://orcid.org/0000-0002-7532-0389
Kristine KwekkeboomCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Shaneda Warren AndersenCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Ajay K SethiDepartment of Population Health Sciences, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Amye J TevaarwerkDepartment of Oncology, Mayo Clinic, Rochester, MN, USA.
Kristin LitzelmanCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Priyanka A PophaliDivision of Hematology, Medical Oncology and Palliative Care, Department of Medicine, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Ronald E GangnonCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
John M HamptonCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Noelle K LoConteCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.
Amy Trentham-DietzCarbone Cancer Center, School of Medicine and Public Health, University of WI-Madison, Madison, WI, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
National Institutes of Health, United States UL1TR002373NCATS NIH HHS UL1 TR002373NCI NIH HHS P30 CA014520NCI NIH HHS P30CA014520
6 · The paper itself

Abstract

purposeFor cancer survivors, self-efficacy is needed to manage the disease and the effects of treatment. The COVID-19 pandemic disrupted cancer-related healthcare, which may have impacted self-management self-efficacy. We investigated self-efficacy reported by cancer survivors during COVID-19, including associations with healthcare disruptions, distress, and general health.

methodsBetween 2020 and 2021, 1902 individuals aged 18-80 years with a recent cancer diagnosis completed a survey regarding the effects of COVID-19 on healthcare, self-efficacy for managing cancer and social interactions, cancer-related distress, and perceived general health. Linear and logistic models estimated odds ratios and 95% confidence intervals (CIs) between self-efficacy scores, healthcare disruptions, significant distress, and general health.

resultsMean self-efficacy for managing cancer was 7.58 out of 10. Greater self-efficacy was associated with lower odds for distress (OR 0.18 [95% CI 0.13-0.26], quartile 4 vs. 1) and for worse general health (0.05 [0.03-0.09]). Participants with disruptions to cancer-related healthcare had lower self-efficacy for managing cancer compared to those without (6.62 vs. 7.09, respectively, P < 0.001) and higher odds for distress (1.70 [1.36-2.14]), but not worse general health (1.13 [0.39-1.44]). Lower self-efficacy mediated 27% of the association between healthcare disruptions and increased distress (15-47%). Associations with self-efficacy for managing social interactions trended in the same direction.

conclusionsDuring COVID-19, disruptions to cancer-related healthcare were associated with lower self-efficacy, increased distress, and worse general health. Psychosocial interventions designed to overcome barriers and target self-efficacy may be important for enhancing outcomes among cancer survivors experiencing disruptions in healthcare access.

Indexed as

Cancer SurvivorsCOVID-19NeoplasmsSelf EfficacySelf-ManagementAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultCancerCOVID-19NeoplasmsSelf-efficacySelf-management

Identifiers

PMID40928529
PMCPMC12423133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.